For localized injury, BPC-157 is often injected SubQ near the injury site
[Google Scholar] 74.Phang JM, Liu W, Hancock CN, Fischer JW
All serious or unexpected adverse reactions (especially allergic responses) should be reported and the therapy re-evaluated
Even losing 10-15 pounds can noticeably reduce symptoms by decreasing the repetitive trauma that prevents complete healing
Safety and side effect profiles Both BPC-157 and TB-500 demonstrate favorable safety profiles across research applications and practical use
It is not intended, marketed, promoted, or sold for injection, reconstitution of any substance for injection, or for any route of administration into humans or animals